Kiniksa Pharmaceuticals International, plc
KNSA
$47.02
$0.521.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.98% | 3.38% | 108.83% | 196.07% | 29.98% |
| Total Depreciation and Amortization | 21.61% | 7.26% | 3.77% | -13.75% | 0.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.89% | 37.26% | -2.32% | 76.18% | 50.90% |
| Change in Net Operating Assets | 2,644.25% | 38.96% | -204.19% | -92.21% | 266.47% |
| Cash from Operations | 60.03% | 19.89% | 25.83% | 18.93% | 939.45% |
| Capital Expenditure | 5.66% | -306.67% | -66.67% | 48.70% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.04% | -1,569.82% | 92.77% | -178.55% | 1,131.60% |
| Cash from Investing | -12.84% | -1,516.15% | 92.47% | -178.94% | 1,128.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.23% | 27.52% | 300.79% | 16.91% | -71.07% |
| Repurchase of Common Stock | 78.91% | -112.65% | -396.84% | 28.72% | 78.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.64% | 11.23% | 286.49% | 29.23% | -67.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.09% | -149.22% | 231.97% | -130.68% | 4,649.08% |